| J9271 | Injection, pembrolizumab, 1 mg | 8,000 | $40 | $344K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 920 | $60 | $58K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 510 | $100 | $52.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 370 | $140 | $51.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 450 | $90 | $41.5K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,500 | $20 | $40K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 240 | $140 | $32.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 16,800 | $1 | $16.8K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 1,000 | $10 | $8K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 100 | $80 | $7.9K |